156 related articles for article (PubMed ID: 35084794)
41. Emerging mutation patterns in SARS-CoV-2 variants.
Ostrov DA; Knox GW
Biochem Biophys Res Commun; 2022 Jan; 586():87-92. PubMed ID: 34837837
[TBL] [Abstract][Full Text] [Related]
42. Mass Screening of SARS-CoV-2 Variants using Sanger Sequencing Strategy in Hiroshima, Japan.
Ko K; Takahashi K; Nagashima S; E B; Ouoba S; Hussain MRA; Akita T; Sugiyama A; Sakaguchi T; Tahara H; Ohge H; Ohdan H; Kubo T; Ishikawa N; Takafuta T; Fujii Y; Mimori M; Okada F; Kishita E; Ariyoshi K; Kuwabara M; Tanaka J
Sci Rep; 2022 Feb; 12(1):2419. PubMed ID: 35165301
[TBL] [Abstract][Full Text] [Related]
43. Tracking SARS-CoV-2 Omicron diverse spike gene mutations identifies multiple inter-variant recombination events.
Ou J; Lan W; Wu X; Zhao T; Duan B; Yang P; Ren Y; Quan L; Zhao W; Seto D; Chodosh J; Luo Z; Wu J; Zhang Q
Signal Transduct Target Ther; 2022 Apr; 7(1):138. PubMed ID: 35474215
[TBL] [Abstract][Full Text] [Related]
44. Structure- and Interaction-Based Design of Anti-SARS-CoV-2 Aptamers.
Mironov V; Shchugoreva IA; Artyushenko PV; Morozov D; Borbone N; Oliviero G; Zamay TN; Moryachkov RV; Kolovskaya OS; Lukyanenko KA; Song Y; Merkuleva IA; Zabluda VN; Peters G; Koroleva LS; Veprintsev DV; Glazyrin YE; Volosnikova EA; Belenkaya SV; Esina TI; Isaeva AA; Nesmeyanova VS; Shanshin DV; Berlina AN; Komova NS; Svetlichnyi VA; Silnikov VN; Shcherbakov DN; Zamay GS; Zamay SS; Smolyarova T; Tikhonova EP; Chen KH; Jeng US; Condorelli G; de Franciscis V; Groenhof G; Yang C; Moskovsky AA; Fedorov DG; Tomilin FN; Tan W; Alexeev Y; Berezovski MV; Kichkailo AS
Chemistry; 2022 Feb; 28(12):e202104481. PubMed ID: 35025110
[TBL] [Abstract][Full Text] [Related]
45. Detection of SARS-CoV-2 and the L452R spike mutation using reverse transcription loop-mediated isothermal amplification plus bioluminescent assay in real-time (RT-LAMP-BART).
Iijima T; Ando S; Kanamori D; Kuroda K; Nomura T; Tisi L; Kilgore PE; Percy N; Kohase H; Hayakawa S; Seki M; Hoshino T
PLoS One; 2022; 17(3):e0265748. PubMed ID: 35312732
[TBL] [Abstract][Full Text] [Related]
46. Discovery of Aptamers Targeting the Receptor-Binding Domain of the SARS-CoV-2 Spike Glycoprotein.
Song Y; Song J; Wei X; Huang M; Sun M; Zhu L; Lin B; Shen H; Zhu Z; Yang C
Anal Chem; 2020 Jul; 92(14):9895-9900. PubMed ID: 32551560
[TBL] [Abstract][Full Text] [Related]
47. Omicron (B.1.1.529) - variant of concern - molecular profile and epidemiology: a mini review.
Kannan S; Shaik Syed Ali P; Sheeza A
Eur Rev Med Pharmacol Sci; 2021 Dec; 25(24):8019-8022. PubMed ID: 34982466
[TBL] [Abstract][Full Text] [Related]
48. Distinct shifts in site-specific glycosylation pattern of SARS-CoV-2 spike proteins associated with arising mutations in the D614G and Alpha variants.
Kuo CW; Yang TJ; Chien YC; Yu PY; Hsu SD; Khoo KH
Glycobiology; 2022 Feb; 32(1):60-72. PubMed ID: 34735575
[TBL] [Abstract][Full Text] [Related]
49. Longitudinal Tracking of Immune Responses in COVID-19 Convalescents Reveals Absence of Neutralization Activity Against Omicron and Staggered Impairment to Other SARS-CoV-2 Variants of Concern.
Odak I; Schultze-Florey CR; Hammerschmidt SI; Ritter C; Willenzon S; Friedrichsen M; Ravens I; Sikora R; Bayir LM; Gutierrez Jauregui R; Bernhardt G; Stankov MV; Cossmann A; Hansen G; Krey T; Cornberg M; Koenecke C; Behrens GMN; Bošnjak B; Förster R
Front Immunol; 2022; 13():863039. PubMed ID: 35359969
[TBL] [Abstract][Full Text] [Related]
50. Molecular and Serological Characterization of the SARS-CoV-2 Delta Variant in Bangladesh in 2021.
Ghosh AK; Kaiser M; Molla MMA; Nafisa T; Yeasmin M; Ratul RH; Sharif MM; Akram A; Hosen N; Mamunur R; Amin MR; Islam A; Hoque ME; Landt O; Lytton SD
Viruses; 2021 Nov; 13(11):. PubMed ID: 34835116
[TBL] [Abstract][Full Text] [Related]
51. Receptor binding, immune escape, and protein stability direct the natural selection of SARS-CoV-2 variants.
Upadhyay V; Lucas A; Panja S; Miyauchi R; Mallela KMG
J Biol Chem; 2021 Oct; 297(4):101208. PubMed ID: 34543625
[TBL] [Abstract][Full Text] [Related]
52. S-acylation of SARS-CoV-2 spike protein: Mechanistic dissection, in vitro reconstitution and role in viral infectivity.
Puthenveetil R; Lun CM; Murphy RE; Healy LB; Vilmen G; Christenson ET; Freed EO; Banerjee A
J Biol Chem; 2021 Oct; 297(4):101112. PubMed ID: 34428449
[TBL] [Abstract][Full Text] [Related]
53. Scanning the RBD-ACE2 molecular interactions in Omicron variant.
Rath SL; Padhi AK; Mandal N
Biochem Biophys Res Commun; 2022 Feb; 592():18-23. PubMed ID: 35007846
[TBL] [Abstract][Full Text] [Related]
54. A Five-Helix-Based SARS-CoV-2 Fusion Inhibitor Targeting Heptad Repeat 2 Domain against SARS-CoV-2 and Its Variants of Concern.
Xing L; Xu X; Xu W; Liu Z; Shen X; Zhou J; Xu L; Pu J; Yang C; Huang Y; Lu L; Jiang S; Liu S
Viruses; 2022 Mar; 14(3):. PubMed ID: 35337003
[TBL] [Abstract][Full Text] [Related]
55. Aptamer Sandwich Lateral Flow Assay (AptaFlow) for Antibody-Free SARS-CoV-2 Detection.
Yang LF; Kacherovsky N; Panpradist N; Wan R; Liang J; Zhang B; Salipante SJ; Lutz BR; Pun SH
Anal Chem; 2022 May; 94(20):7278-7285. PubMed ID: 35532905
[TBL] [Abstract][Full Text] [Related]
56. A Universal DNA Aptamer that Recognizes Spike Proteins of Diverse SARS-CoV-2 Variants of Concern.
Zhang Z; Li J; Gu J; Amini R; Stacey HD; Ang JC; White D; Filipe CDM; Mossman K; Miller MS; Salena BJ; Yamamura D; Sen P; Soleymani L; Brennan JD; Li Y
Chemistry; 2022 Mar; 28(15):e202200524. PubMed ID: 35218097
[TBL] [Abstract][Full Text] [Related]
57. The Development of Aptamer-Based Gold Nanoparticle Lateral Flow Test Strips for the Detection of SARS-CoV-2 S Proteins on the Surface of Cold-Chain Food Packaging.
Li X; Wang J; Yang G; Fang X; Zhao L; Luo Z; Dong Y
Molecules; 2024 Apr; 29(8):. PubMed ID: 38675595
[TBL] [Abstract][Full Text] [Related]
58. Glycosylation of Receptor Binding Domain of SARS-CoV-2 S-Protein Influences on Binding to Immobilized DNA Aptamers.
Grabovenko F; Nikiforova L; Yanenko B; Ulitin A; Loktyushov E; Zatsepin T; Zavyalova E; Zvereva M
Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008982
[TBL] [Abstract][Full Text] [Related]
59. Repurposing CRISPR/Cas to Discover SARS-CoV-2 Detecting and Neutralizing Aptamers.
Zhang J; Zhu A; Mei M; Qu J; Huang Y; Shi Y; Xue M; Zhang J; Zhang R; Zhou B; Tan X; Zhao J; Wang Y
Adv Sci (Weinh); 2023 Aug; 10(22):e2300656. PubMed ID: 37204115
[TBL] [Abstract][Full Text] [Related]
60. Computational Analysis of Short Linear Motifs in the Spike Protein of SARS-CoV-2 Variants Provides Possible Clues into the Immune Hijack and Evasion Mechanisms of Omicron Variant.
Soorajkumar A; Alakraf E; Uddin M; Du Plessis SS; Alsheikh-Ali A; Kandasamy RK
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
